IDEX(US:IEX)2024-04-24 16:10Financial Performance - IDEX reported Q1 2024 sales of $801 million, a decrease of 6% organically compared to Q1 2023[29] - Adjusted EBITDA margin for Q1 2024 was 26%, a decrease of 120 bps compared to Q1 2023's 27.2%[29] - Adjusted EPS for Q1 2024 was $1.88, a decrease of 10% compared to Q1 2023's $2.09[29] - Free cash flow for Q1 2024 was $137 million, an increase of 13% compared to Q1 2023's $121 million[29] Segment Performance - Health & Science Technologies (HST) - HST orders decreased by 2% organically in Q1 2024[4] - HST sales decreased by 13% organically in Q1 2024[4] - Adjusted EBITDA margin for HST was 26.2% in Q1 2024, a decrease of 250 bps[4] Segment Performance - Fire & Safety / Diversified Products (FSDP) - FSDP orders increased by 10% organically in Q1 2024[7] - FSDP sales increased by 2% organically in Q1 2024[7] - Adjusted EBITDA margin for FSDP increased by 40 bps to 28.9% in Q1 2024[8] Segment Performance - Fluid & Metering Technologies (FMT) - FMT sales decreased by 3% organically in Q1 2024[34] - Adjusted EBITDA margin for FMT was 33.6% in Q1 2024, an increase of 60 bps[42,44] 2024 Guidance - The company estimates full year 2024 adjusted diluted EPS to be in the range of $8.15 to $8.45[46] - The company estimates full year 2024 net sales to be in the range of $3,320.3 million to $3,385.6 million[46]